[A pharmacokinetic study of intra-arterial chemotherapy for prophylactic treatment of liver metastasis after hepatectomy for liver cancer]

Gan To Kagaku Ryoho. 1992 Aug;19(10 Suppl):1544-6.
[Article in Japanese]

Abstract

As a fundamental study of efficacy of intra-arterial administration using ADM, ERB and MMC for prophylactic treatment of liver metastasis after hepatectomy for liver cancer, the pharmacokinetics of three drugs (ADM 10mg (n = 5), ERB 20mg (n = 3) and MMC 6 mg (n = 3)) were studied in patients who underwent hepatectomy after intra-arterial injection. The hepatic extraction calculated from the areas under the plasma concentration time curve of both administrations was 40% in ADM, 60% in ERB, and 0% in MMC. From these findings, it is suggested that intra-arterial administration could reduce by half the systemic toxic side effects of ADM or ERB, but the advantage of intraarterial infusion of MMC was not obvious.

Publication types

  • English Abstract

MeSH terms

  • Chemotherapy, Adjuvant
  • Doxorubicin / administration & dosage
  • Doxorubicin / pharmacokinetics*
  • Epirubicin / administration & dosage
  • Epirubicin / pharmacokinetics*
  • Hepatectomy*
  • Hepatic Artery
  • Humans
  • Infusions, Intra-Arterial
  • Infusions, Intravenous
  • Liver / metabolism
  • Liver Neoplasms / metabolism
  • Liver Neoplasms / prevention & control*
  • Liver Neoplasms / surgery
  • Mitomycin / administration & dosage
  • Mitomycin / pharmacokinetics*
  • Neoplasm Recurrence, Local / prevention & control*
  • Postoperative Care

Substances

  • Epirubicin
  • Mitomycin
  • Doxorubicin